Liquid anti-solvent recrystallization to enhance dissolution of CRS 74, a new antiretroviral drug

Abstract : This study concerns a new compound named CRS 74 which has the property of inhibiting Human Immunodeficiency Virus (HIV) protease, an essential enzyme involved in HIV replication process. It is proved in this study that the original CRS 74 exhibits poor aqueous solubility and a very low dissolution rate, which can influence its bioavailability and clinical response. In an attempt to improve the dissolution rate, CRS 74 was recrystallized by liquid anti-solvent (LAS) crystallization. Ethanol was chosen as solvent and water as the anti-solvent. Recrystallized solids were compared with the original drug crystals in terms of physical and dissolution properties. Recrystallization without additives did not modify the CRS 74 dissolution profile compared to the original drug. CRS 74 was then recrystallized using different additives to optimize the process and formulate physicochemical properties. Steric stabilizer in organic phase ensured size-controlling effect, whereas electrostatic stabilizer in aqueous phase decreased particle agglomeration. Cationic additives avoided drug adsorption onto stainless steel T-mixer. In general, additive improved drug dissolution rate due to improvement of wetting properties by specific interactions between the drug and the additives, and ensured continuous production of CRS 74 by electrostatic repulsion.
Liste complète des métadonnées

Cited literature [19 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-01611005
Contributor : Imt Mines Albi Ecole Nationale Supérieure Des Mines d'Albi-Carmaux <>
Submitted on : Wednesday, September 5, 2018 - 4:36:11 PM
Last modification on : Thursday, September 6, 2018 - 10:14:08 AM
Document(s) archivé(s) le : Thursday, December 6, 2018 - 7:27:26 PM

File

Liquid-anti-solvent.pdf
Files produced by the author(s)

Identifiers

Citation

Suenia de Paiva Lacerda, Fabienne Espitalier, Valerie Hoffart, Maria Inês Ré. Liquid anti-solvent recrystallization to enhance dissolution of CRS 74, a new antiretroviral drug. Drug Development and Industrial Pharmacy, Taylor & Francis, 2015, 41 (11), pp.1910-1920. ⟨http://www.tandfonline.com/doi/full/10.3109/03639045.2015.1020812⟩. ⟨10.3109/03639045.2015.1020812⟩. ⟨hal-01611005⟩

Share

Metrics

Record views

193

Files downloads

67